Marilena Vrana: Securing Sustainable Plasma Supply for Europe’s Growing Patient Needs
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared a post on LinkedIn:
“I was glad to join with my PPTA colleagues Anita Brikman, James Knowles and Halide Tuna, the 2026 IPFA/EBA Symposium on Plasma Collection and Supply in Leuven this week.
The discussions focused on both progress and ongoing challenges in meeting plasma need for the growing patient need for plasma-derived medicines, including immunoglobulins and other life-saving and life-enabling therapies.
During the exchanges with peers, I emphasized that ‘self-sufficiency’ should be addressed through a multi-stakeholder dialogue that includes patients and physicians. It must be viewed through the lens of European strategic autonomy – not only national capacity and self-sufficiency – and grounded in actual patient need.
While patient need is still not comprehensively recorded across all Member States, data show that it continues to grow steadily in Europe and globally, driven by improved diagnostic technologies, new indications, and evolving disease detection strategies.
Ensuring patients’ long-term peace of mind requires that we align policy ambition with real-world demand.
There is a clear opportunity for more aligned strategies across stakeholders – from streamlining contract fractionation arrangements to strengthening resilient supply chains that better serve patients in Europe and beyond.
Stronger public-private partnerships, supported by data and best practices, will be critical to closing availability gaps and advancing our collective responsibility to secure long-term sustainability of supply.
I look forward to continuing the dialogue at PPC2026 in Milan – an important checkpoint for our community – where the private sector’s role in strengthening Europe’s Resilience, Reach and Responsibility in plasma and plasma derived medicines will be further discussed.
Together, we can continue moving faster and further in delivering for all patients.”
Find more posts featuring Marilena Vrana on Hemostasis Today.
-
May 25, 2026, 10:30Rob Mac Sweeney: Prevention and Treatment of Thrombosis in Patients With Decompensated Cirrhosis
-
May 25, 2026, 07:34Wolfgang Miesbach: The Maastricht Bleeding Cohort and The High Prevalence of BDUC in Women
-
May 25, 2026, 07:31Maya Brown-Zimmerman: Bridging Patient Experience and Genetic Counseling in Marfan Syndrome
-
May 25, 2026, 05:25Abdullah Mohsin: Automated Detection of DVT Using Deep Learning and Doppler Ultrasound
-
May 25, 2026, 05:07The Dual Role of PAI-1 Mutations in Bleeding and Thrombotic Disorders – ICHCC
-
May 25, 2026, 05:04Fibrinogen αC Domain Lysines Drive Plasminogen Binding and Plasmin Generation – JTH
-
May 25, 2026, 04:50Gülşah Türkoğlu: An Encouraging Momentum Around the Adoption of Resolutions on Stroke Care at WHA79
-
May 25, 2026, 04:47Krishnakant Prasad: A Quick Clinical Review of Renal Papillary Necrosis
-
May 25, 2026, 04:40Rajiv Kumar Jain: World Health Assembly Adopts First-Ever Global Resolution on Stroke Prevention and Care